These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16029022

  • 21. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W, Platt R, Johnson W, Roof M, Vaughn E, Roth JA.
    Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):99-115. PubMed ID: 16165219
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G, de Oliveira E, Krikorian D, Feijlbrief M, Jakab A, Tsikaris V, Sakarellos C, Welling-Wester S, Andreu D, Hudecz F.
    Bioconjug Chem; 2003 Jan 15; 14(6):1260-9. PubMed ID: 14624643
    [Abstract] [Full Text] [Related]

  • 23. CEL-1000--a peptide with adjuvant activity for Th1 immune responses.
    Charoenvit Y, Goel N, Whelan M, Rosenthal KS, Zimmerman DH.
    Vaccine; 2004 Jun 23; 22(19):2368-73. PubMed ID: 15193396
    [Abstract] [Full Text] [Related]

  • 24. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
    Jezek J, El Ridi R, Salah M, Wagih A, Aziz HW, Tallima H, El Shafie MH, Khalek TA, Ammou FF, Strongylis C, Moussis V, Tsikaris V.
    Biopolymers; 2008 Jun 23; 90(3):349-57. PubMed ID: 17549696
    [Abstract] [Full Text] [Related]

  • 25. Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen.
    Yiannaki E, Vlachoyiannopoulos PG, Manoussakis MN, Sakarellos C, Sakarellos-Daitsiotis M, Moutsopoulos HM, Tzioufas AG.
    Clin Exp Immunol; 2000 Sep 23; 121(3):551-6. PubMed ID: 10971524
    [Abstract] [Full Text] [Related]

  • 26. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y, Zhang DM, Pan WQ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct 30; 26(5):327-31. PubMed ID: 19157293
    [Abstract] [Full Text] [Related]

  • 27. Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptides.
    Sakarellos-Daitsiotis M, Tsikaris V, Vlachoyiannopoulos PG, Tzioufas AG, Moutsopoulos HM, Sakarellos C.
    Methods; 1999 Sep 30; 19(1):133-41. PubMed ID: 10525449
    [Abstract] [Full Text] [Related]

  • 28. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C, Doolan DL.
    Mol Immunol; 2007 Apr 30; 44(11):3037-48. PubMed ID: 17303242
    [Abstract] [Full Text] [Related]

  • 29. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O.
    Vaccine; 2006 Mar 10; 24(11):1800-10. PubMed ID: 16310900
    [Abstract] [Full Text] [Related]

  • 30. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 31. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL, Cloninger C, Kochi SK, Thomas LJ, Tinge SA, Rouskey C, Killeen KP.
    Vaccine; 2007 Dec 12; 25(51):8574-84. PubMed ID: 18045752
    [Abstract] [Full Text] [Related]

  • 32. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
    Sugauchi F, Wang RY, Qiu Q, Jin B, Alter HJ, Shih JW.
    J Infect Dis; 2006 Feb 15; 193(4):563-72. PubMed ID: 16425136
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
    Hu ZY, He P, Fang X, Qiu SH, Liang ZL, Li HM, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug 15; 29(8):810-4. PubMed ID: 19103120
    [Abstract] [Full Text] [Related]

  • 34. Variable epitope library-based vaccines: shooting moving targets.
    Pedroza-Roldan C, Charles-Niño C, Saavedra R, Govezensky T, Vaca L, Avaniss-Aghajani E, Gevorkian G, Manoutcharian K.
    Mol Immunol; 2009 Dec 15; 47(2-3):270-82. PubMed ID: 19853920
    [Abstract] [Full Text] [Related]

  • 35. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 15; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 36. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J, Ngai N, Stone GW, Yue FY, Ostrowski MA.
    Vaccine; 2009 Aug 13; 27(37):5077-84. PubMed ID: 19573639
    [Abstract] [Full Text] [Related]

  • 37. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.
    Cong H, Gu QM, Yin HE, Wang JW, Zhao QL, Zhou HY, Li Y, Zhang JQ.
    Vaccine; 2008 Jul 23; 26(31):3913-21. PubMed ID: 18555564
    [Abstract] [Full Text] [Related]

  • 38. Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.
    Barve M, Bender J, Senzer N, Cunningham C, Greco FA, McCune D, Steis R, Khong H, Richards D, Stephenson J, Ganesa P, Nemunaitis J, Ishioka G, Pappen B, Nemunaitis M, Morse M, Mills B, Maples PB, Sherman J, Nemunaitis JJ.
    J Clin Oncol; 2008 Sep 20; 26(27):4418-25. PubMed ID: 18802154
    [Abstract] [Full Text] [Related]

  • 39. Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.
    Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I.
    J Med Chem; 2008 Jan 10; 51(1):167-72. PubMed ID: 18072728
    [Abstract] [Full Text] [Related]

  • 40. Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine.
    Sáenz L, Neira-Carrillo A, Paredes R, Cortés M, Bucarey S, Arias JL.
    Int J Pharm; 2009 Mar 18; 369(1-2):64-71. PubMed ID: 19041932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.